As of May 31, 2025, Advanced Biomedical Technologies Inc (ABMT) reports a Net Margin of -543.73%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Advanced Biomedical Technologies Inc's Net Margin
Over recent years, Advanced Biomedical Technologies Inc's Net Margin has shown limited historical data. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2020-10-31 | -543.73% |
| 2019-10-31 | -8137.39% |
This trend highlights how Advanced Biomedical Technologies Inc manages its overall profitability and cost control over time.
Comparing Advanced Biomedical Technologies Inc's Net Margin to Peers
To better understand Advanced Biomedical Technologies Inc's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Advanced Biomedical Technologies Inc (ABMT) | -543.73% |
| PAVmed Inc (PAVM) | 1328.58% |
| United American Healthcare Corp (UAHC) | -23.77% |
| Remedent Inc (REMI) | -80.63% |
| Paradigm Medical Industries Inc (PDMI) | -86.59% |
| Positron Corp (POSC) | -176.26% |
Compared to its competitors, Advanced Biomedical Technologies Inc's Net Margin is about average compared to peers, reflecting typical industry profitability.